Feature Channels: Heart Disease

• share
• favorite_border

The Cardiovascular Research Foundation® (CRF®) has announced New York Valves: The Structural Heart Summit will feature 12 Late-Breaking Clinical Trials and Science presentations. New York Valves 2024, the expanded iteration of our renowned annual Transcatheter Valve Therapy (TVT®) conference, will take place June 5-7, 2024, at the Jacob K. Javits Convention Center, North in New York City.

• share
• favorite_border

Current methods to model or correct mutations in live cells are inefficient, especially when multiplexing — installing multiple point mutations simultaneously across the genome. Researchers from the UC San Diego have developed new, efficient genome editing tools called multiplexed orthogonal base editors (MOBEs) to install multiple point mutations at once.

• share
• favorite_border

Atrium Health Wake Forest Baptist and Forsyth County EMS have launched a program, believed to be the first in North Carolina, designed to improve outcomes for patients suffering from cardiac arrest.

• share
• favorite_border

A collaborative NIH-funded team is using AI to mine common chest CT scans to predict mortality. Their research identified a collection of cardiac factors that were predictive of death in a large group of patients, potentially setting the stage for improved cardiac screening.

• share
• favorite_border

Investigators from the Smidt Heart Institute at Cedars-Sinai are presenting more than 40 original research studies at the Heart Rhythm Society annual meeting in Boston, May 16-19.

• share
• favorite_border

The designation means OMC-Baton Rouge meets The Joint Commission's designation for readiness to treat patients who experience severe stroke.

• share
• favorite_border

Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels. Their findings, recently published in Circulation, could lead to new therapies for people with endothelial dysfunction, a type of disorder that contributes to coronary artery disease that may occlude with plaque and lack ability to carry sufficient blood into the heart tissue causing a heart attack.

• share
• favorite_border

The first U.S. heart patient involved in a study for a new gene-editing therapy has successfully been treated at MedStar Washington Hospital Center.

• share
• favorite_border

Scientists have designed a new artificial intelligence model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease.

• share
• favorite_border

NASSAU, Bahamas, April 26, 2024 /PRNewswire/ -- Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its cutting-edge JuxtaFlow® Renal Assist Device (RAD). This landmark recognition, fueled by the encouraging outcomes of the BIPASS-AKI feasibility study, coincides with the unveiling of pioneering research at the Society of Cardiovascular Anesthesiologists (SCA) Annual Meeting. It marks a significant leap forward in safeguarding kidney function for patients undergoing cardiac surgeries, addressing a key challenge in cardiothoracic surgery and critical care.

• share
• favorite_border

The American Heart Association has named MedStar Washington Hospital Center Cardiologist Reginald Robinson, MD, its 2024 Physician of the Year. Dr. Robinson has more than two decades of service and leadership with AHA and has worked in the field of cardiology to improve the care of patients and the community.

• share
• favorite_border

Surgeons from the Smidt Heart Institute at Cedars-Sinai will be attending the American Association for Thoracic Surgery (AATS) Annual Meeting April 27-30 in Toronto and are available to discuss the latest cardiac surgery news and research.

• share
• favorite_border

As patients with congenital heart diseases live longer, researchers are attempting to understand some of the other complications they may face as they age. In a new study, a team from Children’s Hospital of Philadelphia (CHOP) used state-of-the-art technologies to understand the underlying biology of Fontan-associated liver disease (FALD).

• share
• favorite_border

An intricate simulation performed by UT Southwestern Medical Center researchers using one of the world’s most powerful supercomputers sheds new light on how proteins called SNAREs cause biological membranes to fuse.

• share
• favorite_border